NASDAQ:MESO • US5907174016
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MESOBLAST LTD- SPON ADR (MESO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-25 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-18 | Jefferies | Downgrade | Buy -> Hold |
| 2025-02-07 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-12-23 | Jefferies | Downgrade | Buy -> Hold |
| 2024-12-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-24 | Maxim Group | Upgrade | Hold -> Buy |
| 2024-08-29 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-29 | Jefferies | Upgrade | Hold -> Buy |
| 2024-07-23 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-04 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-09-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-31 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-31 | Jefferies | Upgrade | Hold -> Buy |
| 2023-08-07 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-08-04 | Chardan Capital | Maintains | Sell -> Sell |
| 2023-08-04 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-08-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-05-30 | Chardan Capital | Maintains | Sell |
| 2023-03-01 | Chardan Capital | Reiterate | Sell |
| 2023-02-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2022-12-06 | Jefferies | Downgrade | Buy -> Hold |
| 2022-09-06 | Piper Sandler | Initiate | Overweight |
| 2022-06-03 | Chardan Capital | Maintains | Sell |
| 2021-08-31 | Chardan Capital | Maintains | Sell |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.501M -26.56% | 5.902M -21.32% | 17.198M 191.39% | 128.05M 644.56% | 177.61M 38.70% | 353.69M 99.14% | 968.95M 173.95% | 942M -2.78% | 1.374B 45.86% | 933.69M -32.05% | 1.136B 21.67% | |
| EBITDA YoY % growth | N/A 12.04% | N/A 30.38% | N/A 3.07% | 303K 100.68% | 71.34M 23,444.55% | 355.02M 397.65% | 805.93M 127.01% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -62.723M 14.97% | -66.886M -6.64% | -82.295M -23.04% | 798.708K 100.97% | 77.929M 9,656.88% | 211.46M 171.35% | 546.15M 158.28% | 614.88M 12.58% | 974.41M 58.47% | 554.35M -43.11% | 719.23M 29.74% | |
| Operating Margin | -836.20% | -1,133.28% | -478.51% | 0.62% | 43.88% | 59.79% | 56.37% | 65.27% | 70.92% | 59.37% | 63.31% | |
| EPS YoY % growth | -1.03 21.99% | N/A -279.39% | N/A 17.29% | -1.40 56.53% | 0.48 134.34% | 3.62 650.54% | 5.97 64.98% | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q2 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.49 59.61% | -0.52 -230.88% | -0.84 73.71% | 0.20 128.32% | -0.06 96.25% | 0.26 150.01% | 0.18 121.47% | 0.95 1,793.40% | 0.50 176.85% |
| Revenue Q2Q % growth | 52.52M 1,564.13% | N/A | 73.023M 420.03% | 23.847M | 24.884M -52.62% | 26.031M | 28.922M -60.39% | N/A | N/A |
| EBITDA Q2Q % growth | -16.16M 63.64% | N/A | 4.04M 108.70% | N/A | 94.94M 687.50% | N/A | 44.44M 1,000.00% | 193.92M 104.26% | 106.05M 138.64% |
| EBIT Q2Q % growth | -12.212M 66.73% | -13.062M | -12.69M 72.17% | 5.705M 144.16% | 5.954M 148.76% | 6.345M 148.57% | 6.803M 153.61% | N/A | N/A |
All data in USD
10 analysts have analysed MESO and the average price target is 18.03 USD. This implies a price increase of 23.22% is expected in the next year compared to the current price of 14.63.
The consensus EPS estimate for the next earnings of MESOBLAST LTD- SPON ADR (MESO) is -1.49 USD and the consensus revenue estimate is 52.52M USD.
The consensus rating for MESOBLAST LTD- SPON ADR (MESO) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.